Enlivex Therapeutics Ltd. (TLV:ENLV)
354.20
+29.60 (9.12%)
At close: Dec 4, 2025
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 95.16 million as of December 5, 2025. Its market cap has increased by 12.27% in one year.
Market Cap
95.16M
Enterprise Value
38.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
354.20
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 95.16M, a decrease of -74.14%. That is a compound annual growth rate of -18.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 105.66B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 1.33B |
| BrainsWay | 1.08B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 997.78M |
| Ilex Medical | 717.72M |
| Novolog (Pharm-Up 1966) | 644.72M |